The Immuno Series US is an exclusive collaborative environment, welcoming over 450 attendees from international Pharma, Biotech & Academic institutions
The 2019 Series in Numbers
Combined figures for last year’s 2nd Advances in Immuno-Oncology USA Congress and 4th Annual Biomarkers & Precision Medicine USA Congress
0
+
Attendees
0
Sponsors & Exhibitors
0
+
Speakers
Attendee Profile
Sector
Geography
USA – 85%
Rest of World – 15%
Function
Companies Represented Include
